← All transactions
Therapixel: €5M Series A from M Capital, Crédit Agricole, Omnes, Région Sud Invest
Exclusive advisor to the company
- Date
- Mar 2019
- Sector
- Healthcare
- Business
- AI medical imaging
- Transaction
- €5M Series A from M Capital, Crédit Agricole, Omnes, Région Sud Invest
- Apparius’s role
- Exclusive advisor to the company
- Area of focus
- Digital health and healthcare services
Based in Sophia Antipolis, Therapixel develops artificial intelligence software for medical imaging, specialising in mammography. Omnes Capital and M Capital Partners joined alongside existing shareholders. The process was run by 13 Advisory, Cédric Goarant's firm, which merged with Apparius in 2019.